• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Oxford University

hand over keys buy house gift takeover acquisition
MedTech

Amber Therapeutics acquires neuromod implant maker Bioinduction

Two years after spinning out of Oxford, Amber is now the proud owner of the tech that serves as the basis for its neuromodulation system.
Andrea Park Sep 5, 2023 10:45am
Ebola Ebola test

Uganda to dole out experimental Ebola shots amid outbreak

Oct 19, 2022 11:30am
cash  money

Oxford Science Enterprises clinches £250M for new startups

Jul 18, 2022 11:26am
Spider web gossamer

Orthox nabs $12M to take artificial cartilage to clinical trials

Feb 9, 2022 11:40am
A vial with a check mark indicating COVID-19 positivity

Axcella jumps into long COVID with phase 2 of midstage NASH drug

Oct 26, 2021 7:00am
Vaccitech scientist

Vaccitech prices $110M IPO with support from original investor

Apr 30, 2021 11:11am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings